J&J’s Icotyde will take on AbbVie’s blockbuster injectable Skyrizi as analysts forecast a blockbuster future for the pill.
Skilled patent practitioner Stuart Nelson deepens the firm’s prosecution and counseling offering for clients across technology driven industries Norton Rose Fulbright – Stuart Nelson Norton Rose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results